Filings in Drug Manufacturer Lawsuits Following HHS’s May 17 Letter

Following a favorable May 17 Letter (the “Letter”) issued by HHS requiring six drug companies to restart 340B pricing on drugs shipped to contract pharmacies or risk civil monetary penalties,…